Biologics
Top 10 Orthopedic Device Firms
-
Biologics | Large Joint
First-in-Human Hyalex Knee Cartilage Treatments Completed
Hyalex cartilage mimics hyaline cartilage’s structure and function, which lets joints have smooth, pain-free motion.Sam Brusco, Associate Editor 04.22.24
-
Biologics
NEOS Cranial LOOP OK'ed for CustomizedBone Use
Cranial LOOP devices are made of biocompatible polymer PEEK-OPTIMA to securely fix bone flaps after craniotomies.Sam Brusco, Associate Editor 04.02.24
-
Biologics
OssDsign Forges Purchasing Contract with Premier Inc.
Agreement for OssDsign Catalyst takes effect July 1.Michael Barbella, Managing Editor 04.02.24
-
Biologics
FDA Approves First-in-Human Trial for RevBio's Regenerative Bone Adhesive
Study will examine the safety and possible benefit of TETRANITE in replacing metal plates and screws in cranial flap fixation.Michael Barbella, Managing Editor 03.22.24
-
Biologics
CMC Considerations for Medical Device-Led Combination Products
Creating antibiotic-loaded orthopedic combination products demands meticulous yet distinct CMC considerations.Nicole Gribbin, Associate Director of Regulatory Affairs, Pharmaceuticals and Biologics, MCRA 03.19.24
-
Biologics
Ventris Medical Gains 510(k) Clearance for Amplify Bone Graft Putty
The putty can be used alone or in combination with autograft bone as a bone graft extender.Sean Fenske, Editor-in-Chief 03.15.24
-
Biologics
FDA OKs SurGenTec's Hydrophilic Synthetic Bone Graft
OsteoFlo HydroPutty features a combination of proprietary hydrophilic carriers to absorb fluids.Sam Brusco, Associate Editor 03.07.24
-
Biologics
Bone Health Technologies Receives $5M in Funding for Osteopenia Care
BHT closes financing round with new investors to reshape bone health for postmenopausal women.Rachel Klemovitch, Assistant Editor 03.06.24
-
Biologics
Bone Solutions' OsteoCrete OK'ed for Intervertebral Body Fusion
According to the company, this is the first, only magnesium-based bone substitute cleared by the FDA for this application.Sam Brusco, Associate Editor 02.13.24
-
Biologics
InGeneron Shares Results From Phase III Knee Osteoarthritis Study
Data show clinical effectiveness in patients and 'confirms an exceptional safety profile' of the company’s cell therapy.Michael Barbella, Managing Editor 02.09.24
-
Biologics | Spine/Neurology
ORTHOSON Earns Breakthrough Status for Bio-Structural Gel for Degenerative Disc Disease
The co-polymer mimics the body’s natural tissue in the nucleus pulpous and restores the disc’s natural function.Sam Brusco, Associate Editor 02.07.24
-
Biologics | Spine/Neurology
Aurora Spine Nabs 2nd U.S. Patent for DEXA Patient-Matched Implant Tech
The new patent will be used to create fusion implants that match the patient’s specific bone density.Sam Brusco, Associate Editor 02.05.24
-
Biologics
BioRestorative Therapies Presenting Preliminary BRTX-100 Trial Data at ORS 2024
BRTX-100 is formulated from autologous cultured mesenchymal stem cells collected from bone marrow.Michael Barbella, Managing Editor 02.05.24
-
Biologics
Bone Health Technologies’ Osteoboost Cleared by FDA
The wearable device is indicated to reduce bone strength and density decline in postmenopausal women and is designed to improve bone health during osteopenia.Charles Sternberg, Associate Editor 01.18.24
-
Biologics
Xenco Unveils TrabeculeX Continuum, a Convergence of Digital Health and Biomaterials
The tool aims to unify biomaterial implantation and the post-op journey.Sam Brusco, Associate Editor 01.16.24
-
Biologics
Robert E. Gagnon Appointed to Bone Biologics Board of Directors
New addition has more than 20 years of experience in finance and business operations at both public and private life sciences companies.Michael Barbella, Managing Editor 01.12.24
-
Biologics
Renovos Biologics Earns Breakthrough Device Designation for Renovite BMP-2
The easy-to-use, injectable gel allows precise, localized bone formation at the target site.Charles Sternberg, Associate Editor 01.04.24
-
Biologics
CGBio Nets FDA Breakthrough Nod for Novosis Putty
Novosis putty is an advanced bone substitute material that incorporates recombinant bone morphogenetic protein 2 (rhBMP-2).Sam Brusco, Associate Editor 01.03.24
-
Biologics
Theragen Receives New Patents for Bone Growth Stimulator System
Demonstrates its contribution to innovation in the field of post-surgical therapeutics, patient engagement, and digital data insights.Charles Sternberg, Associate Editor 12.15.23
-
Biologics
OssDsign Realigning its Strategy to Focus on Orthobiologics
Company’s patient-specific cranial implant business is being phased out.Michael Barbella, Managing Editor 12.11.23
